Cramer Bullish on Streamlined Becton, Dickinson, Forecasts Strong Guidance
Jim Cramer highlighted Becton, Dickinson’s streamlined post-spinoff structure and said he “really likes the new company,” forecasting a positive outlook for its medical device unit. He cited intense competition in pulse field ablation among peers and expects Becton, Dickinson to deliver strong guidance on its next earnings call.
1. Bullish Endorsement from Jim Cramer
Jim Cramer said he “really likes” the revamped Becton, Dickinson and expects the streamlined business to issue an optimistic forecast for its medical device division on the upcoming earnings call.
2. Operational Restructuring
The company recently completed a spinoff of its Biosciences & Diagnostic Solutions businesses to concentrate on core medical supplies, diagnostics and lab equipment, aiming to improve margins and operational agility.
3. Competitive Distribution Landscape
Cramer noted fierce rivalry in pulse field ablation that has pressured peers like Boston Scientific, suggesting BD’s focused distribution network could outperform given these market headwinds.